The Norway-based company offers specialized services in the development and production of liquid medicines, with a core focus on unit-dose Blow-Fill-Seal (BFS) technology, which ensures quality, ready and robust process with minimal human intervention. In addition to BFS, Curida also manufactures nasal spray and bottled products, catering to healthcare providers and enabling them to obtain proper pharmaceutical and tested products for multiple patients. With over 40 years of experience, Curida has established itself as a premium quality manufacturing partner for international pharma companies, working with both small biotech and Big Pharma. The company's lean and flexible organization allows for strong partnerships with its customers.